产品名称 | ReVacc Scientific D71N96 | Human Anti-SARS-CoV-2 Spike RBD IgA Titer Serologic Assay Kit |
---|---|
目录号 | D71N96 |
别名 | Human Anti-SARS-CoV-2 Spike RBD IgA Titer Serologic Assay Kit |
外观 | 见COA |
分子量 | N/A |
CAS | N/A |
溶解度 | |
存储条件 | 见COA |
保存时间 | 见COA |
备注1 | |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
D71N96 | 96-well | 咨询 | 咨询 |
ReVacc Scientific D71N96 | Human Anti-SARS-CoV-2 Spike RBD IgA Titer Serologic Assay Kit
品名:Human Anti-SARS-CoV-2 Spike RBD IgA Titer Serologic Assay Kit
货号:D71N96
品牌:ReVacc Scientific
规格:96-well
产品描述
Organism:Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused the pandemic of COVID-19. The receptor-binding domain (RBD) subunit of the spike protein is to bind to its receptor on target cell surface (ACE2). A rapid and effective assay kit detecting the levels of anti-SARS-CoV-2 Spike RBD in human serum can facilitate research on antibodies produced in response to SARS-CoV-2 infection or vaccines.
This kit was tested to bind to monoclonal antibodies in IgA format (Cat. No. Q74F36) or human sera, see figures.
This kit is developed for serologic test for human IgA titer of Anti-SARS-CoV-2 RBD of Spike (Wuhan Strain) antibody from serum/plasma or other tissues (e.g. mucosal samples) in vitro. It is for research use only. Antibodies of IgM and IgA class are a sign of an active infection (primary infection and reactivation) and disappear during convalescence. In some cases they can persist for several months.